Medical Properties Trust, Inc. (NYSE:MPW) Position Cut by Cambridge Investment Research Advisors Inc.

Cambridge Investment Research Advisors Inc. lowered its position in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 0.9% in the 1st quarter, Holdings Channel reports. The fund owned 464,097 shares of the real estate investment trust’s stock after selling 4,315 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in Medical Properties Trust were worth $2,799,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Y Intercept Hong Kong Ltd raised its holdings in shares of Medical Properties Trust by 506.8% during the fourth quarter. Y Intercept Hong Kong Ltd now owns 63,207 shares of the real estate investment trust’s stock valued at $250,000 after buying an additional 52,790 shares during the last quarter. Proficio Capital Partners LLC acquired a new stake in Medical Properties Trust in the 4th quarter valued at approximately $91,000. Metis Global Partners LLC increased its position in Medical Properties Trust by 11.4% in the 4th quarter. Metis Global Partners LLC now owns 68,825 shares of the real estate investment trust’s stock valued at $272,000 after acquiring an additional 7,034 shares during the period. Jones Financial Companies Lllp raised its stake in Medical Properties Trust by 71.2% during the 4th quarter. Jones Financial Companies Lllp now owns 45,112 shares of the real estate investment trust’s stock valued at $178,000 after acquiring an additional 18,754 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in Medical Properties Trust by 1.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 8,838,540 shares of the real estate investment trust’s stock worth $34,912,000 after acquiring an additional 118,577 shares during the period. Institutional investors own 71.79% of the company’s stock.

Medical Properties Trust Stock Down 3.4%

MPW stock opened at $4.31 on Tuesday. The firm has a market cap of $2.59 billion, a PE ratio of -1.56 and a beta of 1.32. Medical Properties Trust, Inc. has a 12 month low of $3.51 and a 12 month high of $6.55. The company has a debt-to-equity ratio of 1.99, a current ratio of 3.23 and a quick ratio of 3.23. The firm has a 50 day simple moving average of $4.80 and a 200 day simple moving average of $4.88.

Medical Properties Trust (NYSE:MPW) last announced its quarterly earnings data on Thursday, May 1st. The real estate investment trust reported $0.14 EPS for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.01). The company had revenue of $223.80 million for the quarter, compared to analyst estimates of $233.80 million. Medical Properties Trust had a negative net margin of 174.35% and a negative return on equity of 31.14%. Medical Properties Trust’s revenue was down 17.5% on a year-over-year basis. During the same quarter last year, the company posted $0.24 EPS. Equities research analysts forecast that Medical Properties Trust, Inc. will post 0.78 earnings per share for the current fiscal year.

Medical Properties Trust Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 17th. Investors of record on Wednesday, June 18th will be paid a $0.08 dividend. The ex-dividend date of this dividend is Wednesday, June 18th. This represents a $0.32 dividend on an annualized basis and a yield of 7.42%. Medical Properties Trust’s dividend payout ratio is currently -11.55%.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. Royal Bank Of Canada decreased their price target on Medical Properties Trust from $5.00 to $4.50 and set a “sector perform” rating for the company in a research note on Monday. Wall Street Zen upgraded shares of Medical Properties Trust from a “sell” rating to a “hold” rating in a research report on Monday, March 3rd. Wells Fargo & Company boosted their price target on shares of Medical Properties Trust from $4.00 to $5.00 and gave the stock an “underweight” rating in a research report on Monday, March 10th. Finally, BNP Paribas raised shares of Medical Properties Trust from a “neutral” rating to an “outperform” rating and upped their price target for the stock from $5.00 to $9.00 in a research note on Wednesday, March 12th. One analyst has rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, Medical Properties Trust currently has an average rating of “Hold” and a consensus price target of $5.67.

Medical Properties Trust Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.